Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer.
Furuse K, Kawahara M, Hasegawa K, Kudoh S, Takada M, Sugiura T, Ichinose Y, Fukuoka M, Ohashi Y, Niitani H; S-1 Cooperative Study Group (Lung Cancer Working Group).
Furuse K, et al. Among authors: niitani h.
Int J Clin Oncol. 2001 Oct;6(5):236-41. doi: 10.1007/pl00012111.
Int J Clin Oncol. 2001.
PMID: 11723745
Clinical Trial.